Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norm D Smith

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
BJU International|July 30, 2013
Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trialScott E Eggener, Michael C Large, Glenn S Gerber, et al.
BJU International|February 26, 2009
Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b diseaseBrian T Helfand, Anne K Mongiu, Donghui Kan, et al.
Urologic Oncology|November 18, 2015
The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomyJoseph J Pariser, Blake B Anderson, Shane M Pearce, et al.
Urology|February 26, 2008
Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta eliminationKent Perry, Larry Wong, Victoria Liu, et al.
The Journal of Urology|August 4, 2015
Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental FactorsNorm D Smith, Sandip M Prasad, Amit R Patel, et al.
Urologic Oncology|October 17, 2017
National Surgical Quality Improvement Program surgical risk calculator poorly predicts complications in patients undergoing radical cystectomy with urinary diversionShay Golan, Melanie A Adamsky, Scott C Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2009
Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomyC Shad Thaxton, Robert Elghanian, Audrey D Thomas, et al.
The Journal of Urology|June 19, 2016
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO GuidelineSam S Chang, Stephen A Boorjian, Roger Chou, et al.
Cancer|December 29, 2025
Molecular alteration profiles characterize intraductal carcinoma of the prostateHarshitha Dudipala, Shayan S Nazari, Isabela Werneck da Cunha, et al.
Clinical Genitourinary Cancer|May 7, 2016
Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial CancerPeter H O'Donnell, Shaheen Alanee, Kelly L Stratton, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
BJU International|July 30, 2013
Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trialScott E Eggener, Michael C Large, Glenn S Gerber, et al.
BJU International|February 26, 2009
Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b diseaseBrian T Helfand, Anne K Mongiu, Donghui Kan, et al.
Urologic Oncology|November 18, 2015
The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomyJoseph J Pariser, Blake B Anderson, Shane M Pearce, et al.
Urology|February 26, 2008
Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta eliminationKent Perry, Larry Wong, Victoria Liu, et al.
The Journal of Urology|August 4, 2015
Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental FactorsNorm D Smith, Sandip M Prasad, Amit R Patel, et al.
Urologic Oncology|October 17, 2017
National Surgical Quality Improvement Program surgical risk calculator poorly predicts complications in patients undergoing radical cystectomy with urinary diversionShay Golan, Melanie A Adamsky, Scott C Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2009
Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomyC Shad Thaxton, Robert Elghanian, Audrey D Thomas, et al.
The Journal of Urology|June 19, 2016
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO GuidelineSam S Chang, Stephen A Boorjian, Roger Chou, et al.
Cancer|December 29, 2025
Molecular alteration profiles characterize intraductal carcinoma of the prostateHarshitha Dudipala, Shayan S Nazari, Isabela Werneck da Cunha, et al.
Clinical Genitourinary Cancer|May 7, 2016
Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial CancerPeter H O'Donnell, Shaheen Alanee, Kelly L Stratton, et al.
Pageof 8